menu
    • menu

    Company profile for Vedanta Biosciences

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against infectious pathogens. Alterations of the human microbiome are increasingly recognized as a key factor in development of immune and infectious diseases. We rationally design medicines bas...
    The human body is an ecosystem. Trillions of microbes call us home. They form the human microbiome, which performs critical functions that preserve our health including modulating our immune system and providing colonization resistance against infectious pathogens. Alterations of the human microbiome are increasingly recognized as a key factor in development of immune and infectious diseases. We rationally design medicines based on consortia of human commensal bacteria to treat disease, using insights from microbial ecology, mucosal immunology, and human interventional studies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vedanta BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    19 Blackstone Street Cambridge, MA 02139
    Telephone
    Telephone
    857-706-1427
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vedantabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vedanta Bio Show Innovative Work on Microbiome-based Therapeutics
    Vedanta Bio Show Innovative Work on Microbiome-based Therapeutics

    09 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260409690480/en/Vedanta-Biosciences-Showcases-Innovative-Work-on-its-Microbiome-based-Therapeutics-at-the-European-Society-of-Clinical-Microbiology-and-Infectious-Diseases-ESCMID-2026-Global-Congress

    BUSINESSWIRE
    09 Apr 2026
    Share Share
    Vedanta 'Significantly' Reduces Headcount To Fund Lead Program
    Vedanta 'Significantly' Reduces Headcount To Fund Lead Program

    16 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vedanta-significantly-reduces-headcount-fund-lead-bacteria-cocktail-program

    FIERCE BIOTECH
    16 Jan 2026
    Share Share
    Vedanta Downsizes 20% Post PhaseII Setback in Ulcerative Colitis
    Vedanta Downsizes 20% Post PhaseII Setback in Ulcerative Colitis

    14 Aug 2025

    // BIOSPACE

    https://www.biospace.com/business/vedanta-downsizes-by-20-after-phase-ii-stumble-in-ulcerative-colitis

    BIOSPACE
    14 Aug 2025
    Share Share
    Vedanta's Live Bacteria Cocktail Fails Phase 2 Colitis Test
    Vedanta's Live Bacteria Cocktail Fails Phase 2 Colitis Test

    13 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vedantas-live-bacteria-cocktail-fails-reduce-ulcerative-colitis-severity-phase-2-trial

    FIERCE BIOTECH
    13 Aug 2025
    Share Share
    PureTech's Vedanta Bio Phase 2 VE303 Results In Nature Medicine
    PureTech's Vedanta Bio Phase 2 VE303 Results In Nature Medicine

    27 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250126745982/en

    BUSINESSWIRE
    27 Jan 2025
    Share Share
    Vedanta Biosciences reveals Phase 2 VE303 results
    Vedanta Biosciences reveals Phase 2 VE303 results

    27 Jan 2025

    // PHARMATIMES

    https://pharmatimes.com/news/vedanta-biosciences-reveals-phase-2-ve303-results/

    PHARMATIMES
    27 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Contact Vedanta Biosciences and get a quotation

    Vedanta Biosciences is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find VE416 bulk offered by Vedanta Biosciences

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search